FILTER

FILTERED INTERVIEW RESULTS

Christiana Bardon

PORTFOLIO MANAGER, BURRAGE CAPITAL, MANAGING DIRECTOR, ONCOLOGY IMPACT FUND, MPM CAPITAL
Burrage Capital speaks to GBR about the current wave of enthusiasm investors are showing towards biotech.

Jay A. Roberts

PRESIDENT & CEO, CANCER GENETICS, INC.
Cancer Genetics has merged with StemoniX and is addressing the challenges of drug discovery using innovative, science-based technologies and a highly-developed focus on the regulatory community.

Kendalle O’Connell

PRESIDENT AND COO, MASSBIO
MassBio explains how it intends to ensure that Massachusetts remains a global leader for life sciences.

Daphne Zohar & Bharatt Chowrira

FOUNDER AND CEO & PRESIDENT AND CHIEF OF BUSINESS AND STRATEGY, PURETECH HEALTH
PureTech Health is expanding swiftly with 24 product candidates that it has invented or initiated, 13 of which are in clinical testing, and two have received FDA clearance.

Peter DeYoung

CEO, PIRAMAL GLOBAL PHARMA
Piramal Global Pharma is responding to growing demand with rapid expansion in the CDMO space.

Gil Roth

PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
PBOA explains why the CDMO sector enjoys a higher profile.

Debbie Hart

FOUNDING PRESIDENT & CEO, BIONJ
BioNJ relates how New Jersey’s thriving life sciences sector is benefitting from a tremendous boost.

Chris Garabedian

CHAIRMAN & CEO, XONTOGENY
Xontogeny explains how it can help young companies to cross the valley of death.

Rajiv Anand

FOUNDER AND CEO, QUARTIC.AI
Quartic AI explains how artificial intelligence and machine learning should be applied in life sciences.

Rajiv Anand

FOUNDER & CEO, QUARTIC AI
"Much of the focus of tech development has been for people in IT and data science. This creates a big barrier to adoption for chemists, biologists or chemical engineers, it is unsustainable. Overcoming those two barriers is the inspiration behind Quartic.ai."

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2022

PARTNER EVENTS